Akèy › Kansè san › New Jersey › Edison
Etid klinik pou Kansè san nan Edison, NJ
13 etid pou Kansè san ap chèche patisipan nan sit nan ak bò kote Edison (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Ap rekriteFaz 3
- Cancer Institute of New Jersey ( Site 0025), New Brunswick · 3 mi lwen
Rutgers University Study of the Genetics of Blood Cancers
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Rutgers University, Piscataway · 2 mi lwen
A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies
Ap rekriteFaz 1
- Rutgers Cancer Institute of New Jersey, Piscataway · 2 mi lwen
Genomic Profiling in Cancer Patients
Ap rekriteEtid obsèvasyon
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi lwen
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
Ap rekriteFaz 2
- Astera Cancer Care ( Site 2732), East Brunswick · 6 mi lwen
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Ap rekriteFaz 1
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi lwen
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Ap rekriteFaz 3
- Rutgers Biomedical and Health Sciences, New Brunswick · 3 mi lwen
A Study of APG-3288 in Relapsed/Refractory Blood Cancers
Ap rekriteFaz 1
- START New Jersey, East Brunswick · 6 mi lwen
A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant
Ap rekriteFaz 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi lwen
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Ap rekriteEtid obsèvasyon
- Robert Wood Johnson/Cancer Institute of New Jersey, New Brunswick · 3 mi lwen
A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant
Ap rekriteFaz 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi lwen
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
Ap rekriteVolontè an sante akeyi
- Memorial Sloan Kettering Basking Ridge (All protocol activities), Basking Ridge · 15 mi lwen
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Ap rekriteFaz 1
- Rutgers Cancer Institute, New Brunswick · 3 mi lwen
Etid Kansè san nan lòt vil
- Houston, TX46 etid
- New York City, NY26 etid
- Boston, MA25 etid
- Washington, DC19 etid
- Baltimore, MD18 etid
- Seattle, WA18 etid
- Los Angeles, CA17 etid
- Durham, NC16 etid
- Chicago, IL15 etid
- Philadelphia, PA14 etid
- Nashville, TN13 etid
- Atlanta, GA13 etid
Lòt etid nan Edison
- Kansè nan tete68 etid
- Kansè Poumon ki pa ti selil47 etid
- Kansè (tout kalite)33 etid
- Kansè pwostat29 etid
- Kansè kolorektal23 etid
- Kansè poumon23 etid
- Myelom Miltip22 etid
- Kansè vejik21 etid
- Kansè Metastatik20 etid
- Kansè ovè20 etid
- Leksemi mieloïd egi20 etid
- Kansè Endomèt19 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.